Targeting CXCR4 in AML and ALL

被引：78
作者：
Cancilla, Daniel [1 ]
Rettig, Michael P. [1 ]
DiPersio, John F. [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
来源：
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
基金：
美国国家卫生研究院;
关键词：
AML; ALL; CXCR4; CXCL12; chemosensitization; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; HEPARIN-INDUCED THROMBOCYTOPENIA; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW NICHE; PLUS G-CSF; HEMATOPOIETIC STEM; CELL MOBILIZATION; THERAPEUTIC RESISTANCE; ANTAGONIST PLERIXAFOR;
D O I：
10.3389/fonc.2020.01672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The interaction of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) blasts with the bone marrow microenvironment regulates self-renewal, growth signaling, as well as chemotherapy resistance. The chemokine receptor, CXC receptor 4 (CXCR4), with its ligand chemokine ligand 12 (CXCL12), plays a key role in the survival and migration of normal and malignant stem cells to the bone marrow. High expression of CXCR4 on AML and ALL blasts has been shown to be a predictor of poor prognosis for these diseases. Several small molecule inhibitors, short peptides, antibodies, and antibody drug conjugates have been developed for the purposes of more effective targeting and killing of malignant cells expressing CXCR4. In this review we will discuss recent results and strategies in targeting CXCR4 with these agents in patients with AML or ALL.
引用
收藏
页数：14
相关论文
共 159 条
[1]   The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression [J].
Abraham, M. ;
Klein, S. ;
Bulvik, B. ;
Wald, H. ;
Weiss, I. D. ;
Olam, D. ;
Weiss, L. ;
Beider, K. ;
Eizenberg, O. ;
Wald, O. ;
Galun, E. ;
Avigdor, A. ;
Benjamini, O. ;
Nagler, A. ;
Pereg, Y. ;
Tavor, S. ;
Peled, A. .
LEUKEMIA, 2017, 31 (11) :2336-2346
[2]   Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers [J].
Abraham, Michal ;
Pereg, Yaron ;
Bulvik, Baruch ;
Klein, Shiri ;
Mishalian, Inbal ;
Wald, Hana ;
Eizenberg, Orly ;
Beider, Katia ;
Nagler, Arnon ;
Golan, Rottem ;
Vainstein, Abi ;
Aharon, Arnon ;
Galun, Eithan ;
Caraco, Yoseph ;
Or, Reuven ;
Peled, Amnon .
CLINICAL CANCER RESEARCH, 2017, 23 (22) :6790-6801
[3]   Modulators of CXCR4 and CXCR7/ACKR3 Function [J].
Adlere, Ilze ;
Caspar, Birgit ;
Arimont, Marta ;
Dekkers, Sebastian ;
Visser, Kirsten ;
Stuijt, Jeffrey ;
de Graaf, Chris ;
Stocks, Michael ;
Kellam, Barrie ;
Briddon, Stephen ;
Wijtmans, Maikel ;
de Esch, Iwan ;
Hill, Stephen ;
Leurs, Rob .
MOLECULAR PHARMACOLOGY, 2019, 96 (06) :737-752
[4]  
Ahn JY, 2013, APPL IMMUNOHISTO M M, V21, P79, DOI 10.1097/PAI.0b013e3182606f4d
[5]   Mobilization and elimination of FLT3-ITD+ acute myelogenous leukemia (AML) stem/progenitor cells by plerixafor, G-CSF, and sorafenib: Phase I trial results in relapsed/refractory AML patients. [J].
Andreeff, Michael ;
Borthakur, Gautam ;
Zeng, Zhihong ;
Kelly, Mary A. ;
Wang, Rui-Yu ;
McQueen, Teresa J. ;
Qiu, Yihua ;
Mak, Duncan ;
Burger, Jan Andreas ;
Daver, Naval Guastad ;
Pemmaraju, Naveen ;
Kadia, Tapan M. ;
Jabbour, Elias ;
Pierce, Sherry ;
Ravandi, Farhad ;
Garcia-Manero, Guillermo ;
O'Brien, Susan Mary ;
Cortes, Jorge E. ;
Kantarjian, Hagop M. ;
Konopleva, Marina .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[6]  
[Anonymous], 2014, BLOOD
[7]  
[Anonymous], 2019, SCI REP UK
[8]   VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia [J].
Bae, Mi Hyun ;
Oh, Sung-Hee ;
Park, Chan-Jeoung ;
Lee, Bo-Ra ;
Kim, Young Jin ;
Cho, Young-Uk ;
Jang, Seongsoo ;
Lee, Je-Hwan ;
Kim, Nayoung ;
Park, Sang Hyuk ;
Lim, Ji-Hun ;
Seo, Eul-Ju ;
Lee, Kyoo-Hyung .
ANNALS OF HEMATOLOGY, 2015, 94 (10) :1631-1638
[9]   Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma [J].
Barbieri, Federica ;
Bajetto, Adriana ;
Thellung, Stefano ;
Wuerth, Roberto ;
Florio, Tullio .
EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) :1093-1109
[10]   New Approaches to the Management of Adult Acute Lymphoblastic Leukemia [J].
Bassan, Renato ;
Bourquin, Jean-Pierre ;
DeAngelo, Daniel J. ;
Chiaretti, Sabina .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (35) :3504-+
12345678910